Critically, the anti-tumor efficacy of PDE10A inhibitors like PF-2545920 and MCI-030 occurs at concentrations that significantly elevate cyclic nucleotides without immediately activating PI3K/AKT feedback loops in responsive tumors. Here, AKT1 is linked to neoplasm.